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املقاومة الشريانية يف أواخر األشهر الثالثة األوىل من احلمل باعتباره مؤشرا الحقا 
على ارتفاع ضغط الدم املرتبط باحلمل
براله�د كو�شت�جي و انو�ش� اإمي�ين
abstract: Objectives: This study aimed to examine the association between indicators of arterial resistance 
occurring late in the first trimester and the subsequent development of pregnancy-related hypertension. 
Methods: This study took place between May 2014 and August 2015 and included 329 consecutive women with 
singleton pregnancies attending the antenatal clinics of a medical college in Karnataka, India, during this period. 
Pulse pressure (PP) and uterine artery Doppler parameters were recorded between 11–14 gestational weeks. 
Consequently, women were followed-up until after delivery for subsequent hypertension. Results: Hypertension 
occurred more frequently if PP was high (17.6% versus 14.4% of pregnancies without high PP; P = 0.713), if a 
diastolic notch (DN) was present (15.1% versus 12.8% of pregnancies with an absent DN; P = 0.612) and if the 
resistive index (RI) was raised (22.2% versus 14.3% of pregnancies without raised RI; P = 0.366). A raised pulsatility 
index (PI) was significantly associated with hypertension (P = 0.013). The risk of hypertension was approximately 
seven-fold higher if two or more arterial resistance indicators were used, except with a present DN plus a raised RI 
or a present DN plus high PP. All arterial resistance indicators showed negative predictability (>85.6%) and good 
specificity (≥95.0%), except for the presence of a DN. A population-specific cut-off PI value of 1.72 had high negative 
predictability (92.8%) and good sensitivity (70.8%) and specificity (65.1%). Conclusion: Raised PI in the late first 
trimester was a significant predictor of hypertension later in pregnancy. A combination of arterial resistance 
indicators may enhance prediction of subsequent hypertension.
Keywords: Vascular Resistance; Pulse Pressure; Uterine Artery; Doppler Ultrasonography; Pregnancy-Induced 
Hypertension; India.
امللخ�ص: الهدف: هدفت هذه الدرا�شة اإىل فح�س العالقة بني عدد من موؤ�رسات املق�ومة ال�رسي�نية التي حتدث يف وقت مت�أخر يف الأ�شهر 
الثالثة الأوىل من احلمل وارتب�طه� بحدوث ارتف�ع �شغط الدم لحق�. الطريقة: اأجريت هذه الدرا�شة يف الفرتة م� بني م�يو 2014 واأغ�شط�س 
2015, و�شملت 329 امراأة ح�مل يف طفل مفرد من الالتي ح�رسن عي�دات م� قبل الولدة يف كلية الطب يف ولية ك�رن�ت�ك�, الهند, على 
التوايل خالل هذه الفرتة. مت قي��س �شغط النب�س و عمل دوبلر املوج�ت فوق ال�شوتية على ال�رسي�ن الرحمي بني 14-11 اأ�شبوع من احلمل. 
وبعد ذلك, متت مت�بعة هوؤلء الن�ش�ء ايل بعد الولدة لرتقب حدوث ارتف�ع �شغط الدم لحق�. النتائج: مت ر�شد حدوث ارتف�ع يف �شغط الدم 
ب�شكل متكرر اإذا ك�ن �شغط النب�س مرتفع� )%17.6 مق�بل %14.4 من ح�لت احلمل ؛ P = 0.713(, اإذا ك�ن هن�ك ارتف�ع يف ال�شق النب�ش�طي 
)%15.1 مق�بل %12.8 من ح�لت احلمل؛ P = 0.612( اأواإذا مت رفع موؤ�رس املق�ومة RI )%22.2 مق�بل %14.3 من ح�لت احلمل؛ 0.366 = 
P(. ك�نت هن�ك عالقة ذات دللة اح�ش�ئية بني ارتف�ع موؤ�رس النب�س )PI( وارتف�ع �شغط الدم )P = 0.013(. وك�ن مع�مل خطورة ارتف�ع 
�شغط الدم حوايل �شبعة اأ�شع�ف اأعلى اإذا مت ا�شتخدام اثنني اأو اأكرث من موؤ�رسات مق�ومة ال�رسايني, اإل مع وجود ال�شق الأنب�ش�طي ب�لإ�ش�فة 
اإىل ارتف�ع موؤ�رس املق�ومة RI اأو ارتف�ع �شغط النب�س. اأظهرت جميع موؤ�رسات املق�ومة ال�رسي�نية تنبوؤا �شلبي� )%85.6>( ودرجة جيدة 
1.72 تنبوؤا  )%95.0≤(, ال يف وجود �شق انب�ش�طي. وك�ن لقيمة قطع موؤ�رس النب�س اخل��شة ب�ل�شك�ن يف حدود  من مع�مل اخل�شو�شية 
 PI ع�يل ال�شلبية )%92.8( وقيمتي ح�ش��شية وخ�شو�شية جيدتني )%70.8( و علي الرتتيب )%65.1(. اخلال�صة: اأظهر اأرتف�ع موؤ�رس النب�س
يف اأواخر الأ�شهر الثالثة الأوىل ارتب�ط� كبريا مع ارتف�ع �شغط الدم يف وقت لحق من احلمل. وجود عدد من موؤ�رسات مق�ومة ال�رسايني قد 
يوؤدي اإىل تعزيز التنبوؤ ب�رتف�ع �شغط الدم يف احلمل لحق�.
 الكلمات املفتاحية: مق�ومة الأوعية الدموية؛ �شغط النب�س؛ ال�رسي�ن الرحمي؛ دوبلر املوج�ت فوق ال�شوتية؛ ارتف�ع �شغط الدم الن�جم
عن احلمل؛ الهند.
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Advances in Knowledge
- Among the studied cohort, a raised uterine artery pulsatility index (PI) in the late first trimester was significantly associated with the 
development of hypertension later in pregnancy.
- Moreover, the risk of subsequently developing hypertension was approximately seven-fold higher if two or more arterial resistance 
indicators in the late first trimester were used in combination, except with certain combinations of indicators.
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During pregnancy, the development of hypertension after 20 gestational weeks is associated with significant maternal and 
fetal morbidity and mortality.1 Along with sepsis and 
haemorrhage, it is one of the three main causes of 
maternal mortality; nearly 15% of deaths are directly 
due to hypertensive disorders.2 As early detection is 
therefore critical, tests to predict pregnancy-related 
hypertension have been developed using the following 
indicators: placental perfusion and vascular resistance 
(e.g. ‘roll-over’ and cold pressor tests and uterine 
artery Doppler evaluations); placental products (e.g. 
proangiogenic and antiangiogenic proteins, human 
chorionic gonadotropin, placental protein 13 and 
inhibin A measurements); renal dysfunction (e.g. frac-
tional urate clearance and microalbuminuria tests); 
and endothelial dysfunction (e.g. fibronectin, P- and 
L-selectin and vascular cell adhesion molecule 1 
assessments).3 Unfortunately, these investigations and 
even proteomic and metabolomic tests have all failed 
individually to provide a reliable means of predicting 
pregnancy-related hypertension.3 This may be because 
most of these tests are carried out after 16 gestational 
weeks, whereas pregnancy-related hypertension by 
definition manifests after 20 gestational weeks; this 
would suggest that the disease pathology occurs 
beforehand, perhaps even during the first trimester 
of pregnancy.4 
Vasospasm is central to the pathology of pregn-
ancy-related hypertension and affects multiple organ 
systems, including uteroplacental circulation. As 
such, analysing arterial compliance is thought to be 
helpful in predicting pregnancy-related hypertension.5 
Arterial compliance in systemic circulation can be 
measured via pulse pressure (PP), while compliance 
in uteroplacental circulation can be gauged using 
uterine artery Doppler flow studies. Previous research 
has shown that a 1 mmHg rise in PP during early 
pregnancy could be associated with a 6% increase 
in the risk of developing pre-eclampsia.6 Similarly, a 
study evaluating the uterine artery pulsatility index 
(PI) demonstrated that there is a greater decrease in 
uterine artery PI between 11–14 gestational weeks 
and 21–25 gestational weeks in pregnancies with 
a normal outcome compared to those with pre-
eclampsia.7 The present study aimed to examine the 
potential association between arterial resistance 
indicators in the late first trimester, including PP and 
uterine artery Doppler flow velocimetry indices, and 
the occurrence of hypertension later in pregnancy.
Methods
This study took place between May 2014 and August 
2015 at a medical college in southern Karnataka, 
India. The inclusion criteria included consecutive 
women who were between 11–14 gestational weeks 
with singleton pregnancies attending antenatal units 
attached to the medical college during the study 
period. Women with a prior history of pregnancy-
related hypertension, those currently taking drugs 
likely to interfere with vasculature or circulation (e.g. 
β-mimetics, aspirin, heparin, vasodilators, smooth 
muscle relaxants, antioxidants or calcium) and known 
cases of vascular disease, autoimmune disorders, 
essential hypertension, renal disease, diabetes mellitus 
or antiphospholipid syndrome were excluded from the 
study. The necessary sample size was calculated based 
on a known incidence of 15% for hypertensive disorders 
of pregnancy, in order to provide a 95% confidence 
interval (CI) and with 80% power, according to the 
following formula:8
where Z is the level of confidence (95%), P is the 
expected prevalence (15%) and d is the desired 
precision (3–5%). These calculations resulted in a 
required sample size of 384. Of the 8,043 deliveries by 
women who underwent antenatal care at the selected 
antenatal clinics during the study period, pregnancy-
related hypertension was present in 1,190 cases 
(14.8%). There were 504 women who met the inclusion 
criteria; however, 33 (6.5%) either miscarried or 
delivered before 32 gestational weeks and 142 (28.2%) 
did not deliver at the hospital. Therefore, a total of 329 
women (65.3%) were included in the final analysis.
At the time of recruitment, each participant’s blood 
pressure (BP) was taken after a 20-minute resting 
period. The BP measurements were taken from the 
brachial artery of the non-dominant arm while sitting, 
Application to Patient Care 
- The findings of the current study indicate that selected indicators of arterial resistance in the late first trimester—including pulse pressure 
(PP) calculated from routinely recorded blood pressure measurements during regular healthcare visits and uterine artery PI determined 
via Doppler ultrasonography during nuchal translucency screening—can be used to predict the development of hypertension later 
in pregnancy.
- However, population-specific reference values for arterial resistance indicators are needed in order to more reliably predict the 
development of pregnancy-related hypertension among specific patient groups.
n = Z2P(1-P)/d2
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using a calibrated mercury sphygmomanometer and 
a cuff with a length of 1.5 times that of the upper arm 
circumference.9 The PP was calculated as the 
difference between systolic and diastolic recordings 
or the first and fifth Korotkoff sounds.10 As there 
was no standard reference range available for PP, 100 
non-pregnant healthy women between 15–40 years 
old were recruited among postgraduates, interns, 
medical students, nursing students and staff nurses 
at the antenatal units for the purposes of recording 
their BP. From their BP measurements, the mean 
PP ± standard deviation of this group was calculated 
to be 38.33 ± 6.44 mmHg. Therefore, for the pregnant 
women, PP was considered low if it was less than two 
standard deviations below this mean (i.e. 25.5 mmHg) 
and high if it was more than two standard deviations 
above this value (i.e. 51.0 mmHg).
Transabdominal obstetric ultrasound scans were 
performed using a HD7 XE ultrasound system (Philips 
Healthcare, Bothell, Washington, USA) or a Voluson 
E10 ultrasound system (GE Healthcare, Bangalore, 
Karnataka, India) equipped with a 3.5-MHz curvi-
linear transducer. The uterine arteries on each side 
were localised at the level of the internal opening 
of the cervix by colour-flow mapping. Pulsed wave 
Doppler ultrasonography was performed with the 
sampling gate set at 2 mm to cover the whole vessel. 
The angle of insonation was maintained at <50°. The 
PI and resistive index (RI) and the mean values of the 
right and left uterine arteries were calculated. For the 
purposes of the study, the reference upper limit for the 
indices was based on previously reported 95th centile 
values of 2.35 and 0.85 for PI and RI, respectively.11,12 
The presence or absence of a diastolic notch (DN) on 
both sides was also noted.
To determine the development of hypertension 
later in pregnancy, the women were followed-up until 
delivery with routine assessment of BP values at each 
antenatal visit. Additionally, a final BP measurement 
for each woman was taken post-delivery just before 
they were discharged from the hospital. A diagnosis 
of hypertension was made when BP measurements 
taken after 20 gestational weeks exceeded 140 mmHg 
systolic and/or 90 mmHg diastolic on two different 
occasions and at least four hours apart, with diastolic 
pressure defined as Korotkoff phase V.13 Throughout the 
duration of the study, BP and Doppler measurements 
were made by different investigators using standard 
protocols.14,15 The investigators were not involved in 
the diagnosis or management of any of the women. 
Pulsed wave Doppler ultrasound measurements 
were not revealed to the obstetricians in charge of 
patient management.
Relative risk (RR) was calculated to determine the 
probability of participants developing hypertension 
with the presence of an arterial resistance indicator 
(high PP, raised PI and RI or the presence of a DN), 
both alone and in various combinations. Sensitivity, 
specificity and positive and negative predictive values 
were calculated for individual Doppler parameters. 
A receiver-operating curve was plotted for PI and RI 
to determine cut-off values for this study population. 
The Statistical Package for the Social Science (SPSS), 
Version 15.0 (IBM Corp., Chicago, Illinois, USA) 
was used for data analysis. A P value of <0.050 was 
considered significant.
This study was evaluated by the Departmental and 
Scientific Committees of Kasturba Medical College, 
Manipal University, Mangalore, Karnataka, and receiv-
ed approval from the institutional ethics committee 
(IEC KMC MLR #04-14/98). All women gave written 
consent before participating in the study.
Results
A total of 329 women were included in the study with 
a mean age of 24.6 ± 4.2 years. There were 59 women 
(17.9%) under 20 years old, 144 between 21–25 years 
old (43.8%), 100 (30.4%) between 26–30 years old and 
26 (7.9%) over 30 years old. Of all the women studied, 
208 (63.2%) were primigravidae. Pregnancy-related 
hypertension was noted in 48 women (14.6%); of these, 
33 women (68.8%) were diagnosed during a prenatal 
check after 32 gestational weeks, while six (12.5%) were 
diagnosed between 28–32 gestational weeks. A total 
of 15 women (31.3%) were diagnosed while in labour 
during admission to the hospital; however, their BP 
reverted to normal within 48 hours of delivery. There 
were 38 babies (11.6%) born weighing less than 2.5 kg.
With regards to arterial resistance indicators, 17 
women (5.2%) had high PP, 251 (76.3%) had a DN 
present, five (1.5%) had a raised PI and nine (2.7%) 
had a raised RI. Hypertension was more likely to 
occur with high PP (17.6% versus 14.4% of pregnancies 
without high PP; P = 0.713). Similarly, hypertension 
was more frequent with the presence of a DN (15.1% 
versus 12.8% without a DN; P = 0.612) and with a 
raised RI (22.2% versus 14.3% without raised RI; 
P = 0.366). There was a significant association between 
raised PI and the development of hypertension (80.0% 
versus 13.6% without raised PI; P = 0.013) [Table 1]. 
PI was found to have positive and negative likelihood 
ratios of 20.7 and 0.9, respectively. 
A combination of different arterial resistance 
indicators were tested in order to find an accurate 
predictor of pregnancy-related hypertension. Women 
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with any combination of at least two indicators had 
an approximately seven-fold higher risk of developing 
hypertension than those without these indicators. 
However, this did not include two combinations—the 
presence of DN and a raised RI or the presence of DN 
and high PP—which resulted in a RR of 1.99 and 2.20, 
respectively. On its own, raised RI did not appear to 
be a predictor of hypertension (RR = 1.55; 95% CI: 
0.44–5.40); however, it augmented RR values for PP 
Table 1: Associations between arterial resistance 
indicators and pregnancy-related hypertension among 
pregnant women between 11–14 gestational weeks 




n (%) P value
Pulse pressure
High* 17 (5.2) 3 (17.6)  
0.713 
Not high 312 (94.8) 45 (14.4)
Diastolic notch 
Present 251 (76.3) 38 (15.1)  
0.612 
Absent 78 (23.7) 10 (12.8)
Pulsatility index
Raised† 5 (1.5) 4 (80.0)  
0.013
Not raised 324 (98.5) 44 (13.6)
Resistive index
Raised‡ 9 (2.7) 2 (22.2)  
0.366
Not raised 320 (97.3) 46 (14.4)
*Pulse pressure of ≥51.0 mmHg. †Pulsatility index of ≥2.35.11 ‡Resistive 
index of ≥0.85.12
Table 2: Relative risk of pregnancy-related hypertension 
according to arterial resistance indicators alone or 
in combination among pregnant women between 
11–14 gestational weeks attending antenatal units in 
Karnataka, India (N = 329)
Indicator Total, n 
(%)
Hypertensive patients
n (%) RR (95% CI)
PP
High* 17 (5.2) 3 (17.6)  
1.22 (0.42–3.33)
Not high 312 (94.8) 45 (14.4)
DN 
Present 251 (76.3) 38 (15.1)  
1.17 (0.61–2.25)
Absent 78 (23.7) 10 (12.8)
PI
Raised† 5 (1.5) 4 (80.0)  
5.90 (3.51–9.88)
Not raised 324 (98.5) 44 (13.6)
RI 
Raised‡ 9 (2.7) 2 (22.2)  
1.55 (0.44–5.40)
Not raised 320 (97.3) 46 (14.4)
PI + RI
Abnormal 2 (0.6) 2 (100.0)  
7.10 (5.43–9.29)
Normal 327 (99.4) 46 (14.1)
PI + DN
Abnormal 4 (1.2) 4 (100.0)  
7.30 (5.61–9.72)
Normal 325 (98.8) 44 (13.5)
PI + PP 
Abnormal 1 (0.3) 1 (100.0)  
6.90 (5.35–9.09)
Normal 328 (99.7) 47 (14.3) 
PI + RI + DN
Abnormal 2 (0.6) 2 (100.0)  
7.10 (5.43–9.29)
Normal 327 (99.4) 46 (14.1)
PI + RI + PP
Abnormal 1 (0.3) 1 (100.0)  
6.90 (5.35–9.09)
Normal 328 (99.7) 47 (14.3)
PI + DN + PP
Abnormal 1 (0.3) 1 (100.0)  
6.90 (5.35–9.09)
Normal 328 (99.7) 47 (14.3)
RI + PP
Abnormal 1 (0.3) 1 (100.0)  
6.90 (5.35–9.09)
Normal 328 (99.7) 47 (14.3)
RI + DN
Abnormal 7 (2.1) 2 (28.6)  
1.99 (0.6–6.65)
Normal 322 (97.9) 46 (14.3)
DN + PP
Abnormal 13 (4.0) 4 (30.8)  
2.20 (0.93–5.22)
Normal 316 (96.0) 44 (13.9)
RI + PP + DN
Abnormal 1 (0.3) 1 (100.0)  
6.90 (5.35–9.09)
Normal 328 (99.7) 47 (14.3)
PI + RI + DN + PP
Abnormal 1 (0.3) 1 (100.0)  
6.90 (5.35–9.09)
Normal 328 (99.7) 47 (14.3)
RR = relative risk; CI = confidence interval; PI = pulsatility index; 
RI = resistive index; DN = diastolic notch; PP = pulse pressure.
*Pulse pressure of ≥51.0 mmHg. †Pulsatility index of ≥2.35.11 ‡Resistive 
index of ≥0.85.12
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(RR = 6.90; 95% CI: 5.35–9.09 in combination versus 
RR = 1.22; 95% CI: 0.42–3.33 alone) and, to some 
extent, for PI as well (RR = 7.10; 95% CI: 5.43–9.29 
in combination versus RR = 5.90; 95% CI: 3.51–9.88 
alone). The presence of a DN alone did not help with 
risk identification (RR = 1.17; 95% CI: 0.61–2.25); 
however, in certain combinations with other indica-
tors, the RR increased (6.9–7.3) [Table 2]. 
In terms of validation of the indicators as predic-
tors of pregnancy-related hypertension, only the 
presence of a DN showed good sensitivity (79.2%); 
the negative predictive value of this indicator was also 
high (87.2%), although specificity (24.2%) and positive 
predictive value (15.1%) were very poor. Raised PI, 
which had shown an association with hypertension, 
failed to be a sensitive marker (8.3%); however, it had 
good specificity (99.6%), a positive predictive value 
of 80.0% and a negative predictive value of 86.4%. 
As indicators, both RI and PP demonstrated poor 
sensitivity (4.2% and 6.3%, respectively), but had high 
specificity (97.5% and 95.0%, respectively) and negative 
predictive values (85.6% each) [Table 3]. 
In order to find specific reference levels for the 
study population, a receiver-operating curve was 
applied to the data. A cut-off value of 1.72 was obtained 
for PI, with increased sensitivity (8.3% versus 70.8%) 
and without a substantial decrease in specificity (99.6% 
versus 65.1%). [Table 4]. It was not possible to derive a 
population-specific cut-off value for RI.
Discussion
In the current study, the incidence of pregnancy-
related hypertension (14.6%) mirrored the incidence 
noted in previous years at the same facility, based on an 
analysis of unpublished statistics. Alarmingly, this rate 
was almost 2.1-times higher than the global estimate 
(6–8%) published by the National High Blood Pressure 
Education Program working group.16 However, of the 
women with hypertension in the present study, almost 
a third were diagnosed during labour; it is possible 
that the rise in BP observed in these women was 
temporary since pregnancy endothelin-1 concen-
trations significantly increase during labour, especially 
with a vaginal delivery.17,18 Therefore, if these cases 
were to be excluded, the incidence would fall to 10.0% 
(n = 33), which is comparable to previously published 
hospital-based incidence/prevalence rates.19 It should 
also be noted that most classifications of pregnancy-
related hypertension exclude pressure recordings 
taken during labour.20 
In general, PP is considered a surrogate 
measurement of vascular compliance.21 Thadhani 
et al. reported significantly higher PP values at 7–15 
gestational weeks among women who subsequently 
developed pre-eclampsia.6 This finding is similar to 
that of the present study, which found that women 
with high PP values at 11–14 gestational weeks more 
frequently developed hypertension later during their 
pregnancy. Increased turbulence, resistance to flow 
and the presence of a DN have also been associated 
with the subsequent development of pregnancy-
related hypertension.22 In the present study, there was 
a marginally higher occurrence of pregnancy-related 
hypertension among patients with a DN; moreover, 
while the presence of a DN alone did not help with 
risk identification, its presence in combination with 
high PP or a raised PI increased the likelihood of 
hypertension occurring. This indicator demonstrated 
good sensitivity and negative predictive value, 
indicating that the absence of a DN late in the first 
Table 3: Validation measures of arterial resistance 





PI RI DN PP
Sensitivity, % 8.3 4.2 79.2 6.3
Specificity, % 99.6 97.5 24.2 95.0
PPV, % 80.0 22.2 15.1 17.6
NPV, % 86.4 85.6 87.2 85.6
PI = pulsatility index; RI = resistive index; DN = diastolic notch; 
PP = pulse pressure; PPV = positive predictive value; NPV = negative 
predictive value.
Table 4: Comparison of reference and population-specific 
pulsatility index cut-off values to predict pregnancy-
related hypertension among pregnant women between 
11–14 gestational weeks attending antenatal units in 









Positive tests 4 1 34 98
Negative tests 44 280 14 183
Sensitivity, % 8.3 70.8
Specificity, % 99.6 65.1
PPV, % 80.0 25.8
NPV, % 86.4 92.8
HTN = hypertension; PPV = positive predictive value; NPV = negative 
predictive value.
*Reference value sourced from Martin M, Bindra R, Curcio P, Cisero S, 
Nicolaides KH. Screening for pre-eclampsia and fetal growth restriction 
by uterine artery Doppler at 11–14 weeks of gestation.11
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trimester reduced the likelihood of subsequent 
pregnancy-related hypertension. On its own, raised 
RI was also not useful as a predictor of hypertension, 
yet the risk of hypertension increased when this 
indicator was combined with PP and, to some extent, PI.
Raised PI was significantly associated with hyper-
tension in the current study. These findings are in 
agreement with those of Plasencia et al., in which a 
steep decrease in uterine artery PI between 11–13.6 
and 21–24.6 gestational weeks was noted among 
normal pregnancies in comparison to those which 
developed pre-eclampsia.7 In a previous study, 
the researchers concluded that maternal variables 
together with uterine artery PI in the first trimester 
provided a sensitive predictor of pre-eclampsia, 
especially of severe early-onset disease.23 Similarly, 
Martin et al. found that screening for pre-eclampsia 
at 11–14 gestational weeks with uterine artery 
Doppler parameters allowed the identification of a 
high proportion of severe pre-eclampsia and/or fetal 
growth restriction cases.11 Nevertheless, although 
the findings from this study agree with earlier studies 
in part, the authors of the current study believe that 
the effect of uterine artery impedance is not uniform. 
Due to their low predictive value, Sciscione et al. 
do not recommend uterine artery Doppler testing 
in either high- or low-risk pregnancies.24 As this 
screening technique is not standardised or universally 
used, the criteria for abnormal values have yet to be 
determined.25 There was wide variation in the findings 
of the current study when different cut-off values 
for pulse wave analysis were used; this was thought 
to be mainly attributable to the use of cut-off values 
for PI and RI sourced from previous studies.11,12 
Indeed, calculations of cut-off values in the current 
study indicated that these were lower for the studied 
Indian population than the reference values for other 
populations.11,12 Therefore, the results of the current 
study would be more comparable if the cut-off values 
had been specific to the study population. 
The current study is subject to a few limitations. 
First, the findings are based on a small number of 
observations and the study included women who 
developed hypertension during labour and late in 
their pregnancies. Second, there were possible inter-
observer variations in the recording of BP and Doppler 
flow measurements; however, it was not possible to 
have a single person record all of the measurements. 
Moreover, inter-observer variations were believed to 
be minimal as the antenatal care facilities attended 
by the patients follow a checklist for recording BP 
and Doppler ultrasonography was performed by 
consultant radiologist-sonologists following a uniform 
protocol with computer-generated Doppler flow 
values. Third, there were very few cases with abnormal 
Doppler flow values at the end of the study, especially 
when combinations of PP, DN, PI and RI were used. 
This drawback could be overcome in future studies 
involving a greater number of cases. In contrast, 
the strengths of this study include the development 
of a cut-off PI value for a local Indian population. 
Furthermore, there is an urgent need for a reliable and 
early indicator of pregnancy-related hypertension. 
Currently, there are no accepted tests for predicting 
the occurrence of hypertension during pregnancy. 
A simple, non-invasive and inexpensive test—such as 
PP as one of the indicators of arterial resistance—may 
be of great help to primary care physicians at remote 
facilities in order to prioritise care, make early 
referrals and provide appropriate counselling for 
pregnant women.
Conclusion
Uterine artery PI in the late first trimester was 
significantly associated with the subsequent develop-
ment of hypertension later in pregnancy. Additionally, 
the use of a combination of arterial resistance indicators 
increased prediction of the subsequent development 
of hypertension. The authors suggest that future 
studies develop population-specific reference cut-off 
values for PI and RI.
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